相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia
Zheng-Li Xu et al.
CLINICAL TRANSPLANTATION (2021)
Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia
Shinichi Kako et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party
Pedro H. Prata et al.
BONE MARROW TRANSPLANTATION (2020)
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT)
Ghada ElGohary et al.
BONE MARROW TRANSPLANTATION (2020)
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies
Xiao-Ning Gao et al.
ANNALS OF HEMATOLOGY (2020)
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
Amy E. DeZern et al.
BLOOD ADVANCES (2020)
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation
Zheng-Li Xu et al.
BONE MARROW TRANSPLANTATION (2019)
Haploidentical donor transplants for severe aplastic anemia
Andrea Bacigalupo et al.
SEMINARS IN HEMATOLOGY (2019)
Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies
Xiao-Ning Gao et al.
ANNALS OF HEMATOLOGY (2019)
Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor
Shiwei Yang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia
Yue Lu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study
Regis Peffault de Latour et al.
BLOOD (2018)
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
Lan-Ping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning
Wu Yamei et al.
ONCOTARGET (2017)
Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia
Amy E. DeZern et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)
Shinya Ishida et al.
ANNALS OF HEMATOLOGY (2016)
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies
Hyoung Jin Kang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia
S-E Lee et al.
BONE MARROW TRANSPLANTATION (2016)
Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study
Lan-Ping Xu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study
Paolo Anderlini et al.
LANCET HAEMATOLOGY (2015)
Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation
Francesco Zallio et al.
CLINICAL TRANSPLANTATION (2013)
Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels
Jakub Tolar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation
Saro H. Armenian et al.
BLOOD (2011)
Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants
B. George et al.
BONE MARROW TRANSPLANTATION (2010)
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party
Andrea Bacigalupo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders
E. Ozyurek et al.
BONE MARROW TRANSPLANTATION (2008)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection
FL Dulley et al.
BONE MARROW TRANSPLANTATION (2004)
Predictors for severe cardiac complications after hematopoietic stem cell transplantation
M Sakata-Yanagimoto et al.
BONE MARROW TRANSPLANTATION (2004)
Predictive value of OT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation
H Nakamae et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue
M Akahori et al.
BONE MARROW TRANSPLANTATION (2003)
Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997
T Murdych et al.
BONE MARROW TRANSPLANTATION (2001)
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction
K Fujimaki et al.
BONE MARROW TRANSPLANTATION (2001)
分享论文
